YK Bioventures Opportunities GP I, LLC

This profile gathers the share dealings of YK Bioventures Opportunities GP I, LLC in Cero Therapeutics Holdings, Inc. We count 3 filings; the first trade dates from 10 October 2024 and the latest from 11 December 2024.

No open-market purchase appears, only 3 sales worth €540k.

The newest entry dates from 13 December 2024: an open-market sale of €102k, in Cero Therapeutics Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.